QUMAS, the leading provider of Compliance Solutions to highly regulated industries, announced the launch of the QUMAS Biotechnology Package, a complete webbased electronic document management system (eDMS) for Biotechnology companies preparing for regulatory submission. This affordable package has been created specifically for small biotech companies, in order to give them access to QUMAS DocCompliance, the leading eDMS used by tier one companies globally. Growing biotechs can now afford a complete eDMS for document control, which is preconfigured with industry practices, and can be validated and live within 30 days.

“We are delighted to be able to provide an affordable offering to smaller companies who can now leverage the same solutions as the leaders in their space in a cost effective and highly efficient package,” said Ken Hayward, CTO of QUMAS. “They can also leverage our expertise, as configured in the system, to ensure that they operate a compliant organization from the outset, making them more viable in a regulatory context and more attractive to investors and partners.”

The QUMAS Biotechnology package is

Easy and fast to implement go live within 30 days
Preconfigured with industry standards for regulatory compliance
Best of breed document management, which is in used in over 250 facilities globally
Extendable and scalable, as the company, the requirements and the infrastructures grow
Easy to use with fast track training built in
Compatible with all existing documents and processes
A cost effective world class solution at an industry leading cost

QUMAS is launching the Biotechnology Package in the EU on September 15, at the DMS Expo in Cologne. QUMAS is launching the Biotechnology Package in the US on September 16, at a Compliance Breakfast Seminar in the Vertex Pharmaceuticals facility in Cambridge, MA. Also speaking at this event will be clients from Vertex Pharmaceuticals and Millennium Pharmaceuticals, along with QUMAS Regulatory experts.

Source